Clinical Trial Update: A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Fulticasone Furoate/Vilanterol versus Tiotropium on arterial stiffness in COPD completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fulticasone Furoate/Vilanterol
• tiotropium (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2013-08-09